Novo Integrated Sciences Income from Continuous Operations 2012-2024 | NVOS

Novo Integrated Sciences income from continuous operations from 2012 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Novo Integrated Sciences Annual Income from Continuous Operations
(Millions of US $)
2024 $-16
2023 $-13
2022 $-33
2021 $-4
2020 $-5
2019 $-0
2018 $-2
2017 $-1
2016 $-0
2016 $-0
2015 $-3
2014 $-1
2013 $-1
2012 $-1
2012 $-1
2011 $-2
2011 $-2
Novo Integrated Sciences Quarterly Income from Continuous Operations
(Millions of US $)
2024-08-31 $5
2024-05-31 $-14
2024-02-29 $-3
2023-11-30 $-5
2023-08-31 $-3
2023-05-31 $-1
2023-02-28 $-5
2022-11-30 $-4
2022-08-31 $-23
2022-05-31 $-4
2022-02-28 $-5
2021-11-30 $-2
2021-08-31 $-2
2021-05-31 $-0
2021-02-28 $-1
2020-11-30 $-1
2020-08-31 $-4
2020-05-31 $-0
2020-02-29 $-1
2019-11-30 $-0
2019-08-31 $0
2019-05-31 $-0
2019-02-28 $-0
2018-11-30 $-0
2018-08-31 $-0
2018-05-31 $-0
2018-02-28 $-1
2017-11-30 $-0
2017-08-31 $-1
2017-05-31 $-0
2017-03-31 $-0
2017-02-28 $-0
2016-12-31
2016-11-30 $-0
2016-09-30 $-0
2016-06-30 $-0
2016-05-31 $-0
2016-03-31 $-0
2015-12-31
2015-09-30 $-0
2015-06-30 $-0
2015-03-31 $-2
2014-12-31
2014-09-30 $-0
2014-06-30 $-0
2014-03-31 $-0
2013-12-31
2013-09-30 $-0
2013-06-30 $-0
2013-03-31 $-0
2012-12-31 $0
2012-09-30 $-0
2012-08-31
2012-06-30 $-0
2012-03-31 $-0
2012-02-29 $-0
2011-12-31
2011-11-30 $-1
2011-09-30 $-1
2011-08-31 $-0
2011-06-30 $-0
2011-05-31 $-1
2011-03-31 $-1
2011-02-28 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.446B 0.00
Quest Diagnostics (DGX) United States $18.204B 18.28
DaVita (DVA) United States $14.448B 18.68
Encompass Health (EHC) United States $10.001B 23.58
Chemed (CHE) United States $8.458B 25.99
Elanco Animal Health (ELAN) United States $5.947B 14.15
Option Care Health (OPCH) United States $5.262B 24.93
RadNet (RDNT) United States $4.847B 107.33
LifeStance Health (LFST) United States $3.050B 0.00
Amedisys (AMED) United States $3.030B 21.56
Addus HomeCare (ADUS) United States $2.270B 26.63
Astrana Health (ASTH) United States $2.074B 28.36
U.S Physical Therapy (USPH) United States $1.339B 35.20
Pennant (PNTG) United States $0.909B 36.76
Aveanna Healthcare Holdings (AVAH) United States $0.889B 0.00
Atai Life Sciences (ATAI) Germany $0.260B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00